Literature DB >> 12464257

Metabolic pathways of dioxin by CYP1A1: species difference between rat and human CYP1A subfamily in the metabolism of dioxins.

Raku Shinkyo1, Toshiyuki Sakaki, Miho Ohta, Kuniyo Inouye.   

Abstract

Metabolism of polychlorinated dibenzo-p-dioxins by CYP1A subfamily was examined by using the recombinant yeast microsomes. In substrate specificity and reaction specificity, considerable species differences between rats and humans were observed in both CYP1A1- and CYP1A2-dependent metabolism of dioxins. Among four CYPs, rat CYP1A1 showed the highest activity toward dibenzo-p-dioxin (DD) and mono-, di-, and trichloroDDs. To reveal the mechanism of dioxin metabolism, we examined rat CYP1A1-dependent metabolism of 2-chloro-dibenzo-p-dioxin. In addition to hydroxylation at an unsubstituted position, hydroxylation with migration of a chloride substituent, hydroxylation with elimination of a chloride substituent, and cleavage of an ether linkage of the dioxin ring were observed. In particular, the cleavage of an ether linkage of the dioxin ring appeared most important for the detoxication of dioxins. Based on these results, the metabolic pathways of 2-chloro-dibenzo-p-dioxin by rat CYP1A1 were proposed. The metabolic pathways contain most of the metabolites observed in vivo using experimental animals, suggesting that P450 monooxygenase systems including CYP1A1 are greatly responsible for dioxin metabolism in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12464257     DOI: 10.1016/s0003-9861(02)00366-1

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

1.  Expression pattern and action analysis of genes associated with the responses to chemical stimuli during rat liver regeneration.

Authors:  Shao-Wei Qin; Li-Feng Zhao; Xiao-Guang Chen; Cun-Shuan Xu
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

2.  The involvement of CYP1A2 in biodegradation of dioxins in pigs.

Authors:  Sylwia Swigonska; Tomasz Molcan; Anna Nynca; Renata E Ciereszko
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

3.  Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD.

Authors:  Claude Emond; Linda S Birnbaum; Michael J DeVito
Journal:  Environ Health Perspect       Date:  2006-09       Impact factor: 9.031

Review 4.  Mammalian cytochrome P450-dependent metabolism of polychlorinated dibenzo-p-dioxins and coplanar polychlorinated biphenyls.

Authors:  Hideyuki Inui; Toshimasa Itoh; Keiko Yamamoto; Shin-Ichi Ikushiro; Toshiyuki Sakaki
Journal:  Int J Mol Sci       Date:  2014-08-13       Impact factor: 5.923

5.  Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice.

Authors:  Y Kapelyukh; C J Henderson; N Scheer; A Rode; C R Wolf
Journal:  Drug Metab Dispos       Date:  2019-05-30       Impact factor: 3.922

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.